Contingency Management for Stimulant Use Disorder: How It Works and How to Find It

Most people looking for help with methamphetamine or cocaine use expect the conversation to open with medication. For opioid use disorder and alcohol use disorder, it often does. Stimulants are different. There is currently no medication approved by the U.S. Food and Drug Administration specifically for the treatment of stimulant use disorder, and that gap leads many families to conclude that nothing effective exists. The opposite is closer to the truth. One of the most consistently supported behavioral treatments in all of addiction care was developed largely for stimulant use, and it is called contingency management.

It is also one of the hardest treatments to find, for reasons that have more to do with funding rules than with clinical evidence. This article explains what contingency management is, how a session actually runs, what the research supports and what it does not, and the specific questions worth asking a program before enrolling. If you are trying to locate a program that offers it, you can also call (866) 644-7911 to talk through options.

Why Stimulant Use Disorder Calls for a Different Approach

Stimulants act on the brain reward system quickly and powerfully. With sustained heavy use, that system tends to become less responsive to ordinary sources of reward, which is part of why people describe early abstinence as flat and colorless rather than simply uncomfortable. The stimulant crash usually presents as heavy sleep, profound fatigue, low mood, increased appetite, and waves of craving. Unlike alcohol or benzodiazepine withdrawal, it is not typically dangerous in the way that seizure risk is dangerous, which is why a stimulant crash is frequently underestimated by everyone around it, including the person going through it.

That difference shapes treatment. There is no taper to manage and no replacement medication to stabilize on. What is missing during those first weeks is reinforcement, the sense that anything is worth doing. Contingency management was built to address exactly that, by supplying a reliable, immediate, external reward for the specific behavior that matters most in the early phase.

What Contingency Management Actually Looks Like

The version most people encounter runs inside an outpatient program over roughly twelve weeks. A person comes to the clinic on a set schedule, often two or three times a week, and gives a urine sample. If the sample is negative for the target substance, they earn something immediately, that day, in the room.

Two structures are common. In a voucher system, each negative sample earns a voucher of a set value that can be exchanged for goods or gift cards. In the prize or fishbowl system, each negative sample earns one or more draws from a bowl, where most slips carry a small value, some carry a larger one, and a very small number carry a substantial prize. The draw is the point as much as the prize is.

In both structures, three design features do the work. Value escalates with each consecutive negative result, so the fourth week is worth meaningfully more than the first. A positive sample or a missed visit resets the schedule to its starting value. And a period of renewed negative results earns the person back up the ladder. What a participant experiences is a visible streak with something real attached to it.

Why the Structure Matters More Than the Amount

People often react to the description with some version of the same objection: you are paying someone not to use drugs. It is a fair reaction, and the answer is about timing rather than money. A stimulant delivers its effect within seconds. The benefits of not using arrive over months, in the form of repaired relationships, steadier work, and returning sleep. Those long-horizon rewards are real, but during the first weeks they are no match for something immediate.

Contingency management puts a small, certain, immediate consequence on the side of abstinence, in the window where nothing else is competing. The escalation gives the streak a shape a person can feel. The reset makes the streak worth protecting. Programs that hand out a flat reward with no escalation, or that deliver it weeks later, tend to lose most of the effect, which is why fidelity to the structure matters more than the size of the budget.

What the Evidence Supports and Where It Stops

Contingency management has been studied across decades of randomized trials in stimulant, cannabis, opioid, and tobacco use, and reviews maintained by the National Institute on Drug Abuse identify it among the behavioral approaches with the strongest support for stimulant use disorder specifically. The Substance Abuse and Mental Health Services Administration has published implementation guidance for programs adopting it, and the American Society of Addiction Medicine addresses incentive-based approaches within its broader treatment criteria.

The honest limit is durability. Effects are clearest while incentives are active and tend to weaken after the program ends, which is the same pattern seen with many time-limited interventions. That is an argument for what contingency management is paired with, not an argument against using it. Programs generally combine it with cognitive behavioral therapy, the community reinforcement approach, recovery housing, employment support, or ongoing counseling, so that the twelve weeks of protected abstinence are spent building something that does not disappear when the vouchers do.

Where It Fits Among the Levels of Care

Contingency management is not a level of care. It is a component delivered inside one. Most often it sits within intensive outpatient programming or standard outpatient treatment, because both already involve regular in-person visits, which the model requires. It can also continue as a step-down after residential treatment.

People who are using stimulants alongside alcohol, benzodiazepines, or opioids may need medically supervised detoxification first, since those substances carry withdrawal risks that stimulants alone do not. A clinical assessment determines placement. For an overview of how programs are tiered and what each tier involves, see our guide to the addiction levels of care.

Why It Has Been So Hard to Find

The scarcity of contingency management in community programs is largely a funding and compliance story. Federal rules that guard against inducing patients to choose a particular provider have historically made organizations cautious about the value of incentives they offer, and many programs limited themselves to amounts well below what trials used. Payers have also been slow to reimburse a service whose central cost is the incentive itself rather than staff time.

That picture has been shifting. Federal agencies have issued clarifying guidance, and several states have run contingency management through Medicaid demonstration authority, particularly in regions facing high rates of methamphetamine use. Availability still varies considerably by state and by program, so it is worth asking directly rather than assuming.

Questions Worth Asking Before Enrolling

• Do you offer contingency management, and is it part of the standard program or an add-on?
• How long does the incentive period run, and how often are visits scheduled?
• Does the value escalate with consecutive negative results, and what happens after a positive one?
• Are incentives vouchers, prize draws, or something else, and roughly what can be earned over the full period?
• What therapy or support runs alongside it, and what continues after the incentive period ends?
• Is the program licensed in this state and accredited, and does it accept my insurance or offer a sliding scale?
• How do you handle co-occurring mental health conditions such as depression, anxiety, or a psychotic episode related to stimulant use?

A program that cannot describe its own escalation and reset rules is probably running an informal version of the model. That is not necessarily useless, but it is not what the research examined.

Safety Considerations That Should Not Wait

Two risks deserve direct attention. The first is overdose. The illicit stimulant supply in many parts of the country now contains fentanyl, sometimes without the knowledge of the person selling it, and the Centers for Disease Control and Prevention has documented the rise in overdose deaths involving stimulants combined with synthetic opioids. Anyone who uses stimulants, and the people around them, should have naloxone available and know how to use it, regardless of whether opioids are the intended substance. Fentanyl test strips are legal in a growing number of states.

The second is psychiatric crisis. Heavy stimulant use and the crash that follows can involve severe depression, paranoia, and suicidal thoughts. If you or someone you are with is thinking about suicide, call or text 988 to reach the Suicide and Crisis Lifeline, which operates around the clock. Call 911 for chest pain, seizures, dangerously high body temperature, severe agitation, or signs of stroke such as sudden weakness or trouble speaking. These are medical emergencies and should be treated as such.

What Contingency Management Does Not Do

It does not treat trauma. It does not resolve unstable housing, an untreated mood disorder, or a legal case. It does not replace the slower work of rebuilding a life, and it is not a cure for stimulant use disorder, which is a chronic condition that tends to involve periods of progress and periods of return to use. A return to use is information about what the plan is missing, not evidence of a moral failing or a reason to stop treatment.

What contingency management reliably does is hold open a window of abstinence long enough for the rest of treatment to take hold. For a condition with no approved medication, that window is worth a great deal.

Finding a Program

Because availability varies by state and payer, locating a program that offers contingency management with genuine fidelity often takes a few calls. State substance use agencies, academic medical centers, and Medicaid managed care plans are reasonable starting points, and SAMHSA operates a free, confidential national helpline that can point toward local treatment. To talk through what is available in your area and how it lines up with insurance, call (866) 644-7911.

This article is for educational purposes only and does not constitute medical advice. It does not replace a clinical assessment by a licensed professional, who can evaluate individual circumstances, co-occurring conditions, and the appropriate level of care. If you are experiencing a medical or psychiatric emergency, call 911. For suicide or mental health crisis support, call or text 988.